RecallRadar

FDA Drug recall D-926-2013

Ketorolac Tromethamine Inj., USP, 30 mg vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-3795-01

On 2013-09-04 the FDA classified a Class II recall of Ketorolac Tromethamine Inj., USP, 30 mg vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-3795-01 by Hospira, citing lack of Assurance of Sterility: Either a loose crimp or no crimp was applied to the fliptop vials.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-926-2013
ClassificationClass II
Statusterminated
Initiated2013-08-12
Published2013-09-04
Last updated2026-09-13 11:51 UTC
CompanyHospira
Distributionn/a

Product

Ketorolac Tromethamine Inj., USP, 30 mg vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-3795-01

Reason

Lack of Assurance of Sterility: Either a loose crimp or no crimp was applied to the fliptop vials.

Identifiers

ndc0409-3793-19
ndc0409-3793-01
ndc0409-3793-25
ndc0409-3795-19
ndc0409-3795-01
ndc0409-3795-25
ndc0409-3796-19
ndc0409-3796-01
ndc0409-3796-25
code_infoLot 25048DK Exp. 01/15

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-926-2013%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.